Global /United States /Healthcare /Drug Manufacturers - Specialty & Generic /UBQU
chevron_leftBack

Ubiquitech Software Corp.

UBQU
OTCMKTS: UBQU Delayed
0.0001USD 10K%
As of 24 April 2025, Ubiquitech Software Corp. has a market cap of $3.18M USD, ranking #36793 globally and #5213 in the United States. It ranks #3735 in the Healthcare sector, and #771 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
36793
Country Rank
5213
Sector Rank
3735
Industry Rank
771
Key Stats
Market Cap
$3.18MUSD
Net Income (TTM)
-$47.56KUSD
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
James Ballas open_in_new
Employees
1
Founded
2007
Website
ubiquitechsoftware.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
10K% 0% 0% 100% 0% 100%

Markets

Exchange Ticker Price
OTC Markets
MIC: OTCM
PRIMARY
UBQU
Ubiquitech Software Corp
ISIN: US9034701022
Shares Out.:
29.082B1 Shares Float: 23.472B2
TV:
SA:
YF:
GF:
BA:
MS:
0.0001 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Ubiquitech Software Corp.

Ubiquitech Software Corp. develops Internet marketing and sales software solutions in the United States. The company’s Internet sales technologies include Blue Crush Monetization System that creates advertising platforms and improves existing platforms to increase sales; InternationalFortune.com, a lead generation portal for currency trading companies, hedge funds, and other asset managers worldwide; and Blue Crush Connect, a social network that rewards and incentivizes customers. It also operates AffiliateCashExpress.com and NeedFunded.com. Ubiquitech Software Corp. was incorporated in 2007 and is based in Denver, Colorado.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (United States)
Name
Market Cap diff.
Zoetis Inc.
ZTS
$67.32B
2M%
United Therapeutics Corp.
UTHR
$13.18B
414K%
Neurocrine Biosciences, Inc.
NBIX
$10.21B
321K%
Viatris Inc.
VTRS
$9.32B
293K%
Lantheus Holdings, Inc.
LNTH
$6.94B
218K%
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
Merck KGaA
MRK
$59.67B
52.43B EUR
2M%
Sun Pharmaceutical Industries Ltd.
SUNPHARMA
$49.13B
4.19T INR
2M%
Takeda Pharmaceutical Company Ltd.
4502
$46.31B
6.6T JPY
1M%
Haleon plc
HLN
$45.68B
34.34B GBP
1M%
Galderma Group AG
GALD
$23.17B
19.13B CHF
729K%